BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5326295)

  • 1. Observations of placebo response in chronic schizophrenic patients.
    Bishop MP; Gallant DM
    Arch Gen Psychiatry; 1966 May; 14(5):497-503. PubMed ID: 5326295
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
    Tetreault L; Bordeleau JM; Gauthier R; Vulpe M; Lapointe L
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:74-84. PubMed ID: 4886994
    [No Abstract]   [Full Text] [Related]  

  • 3. Chlorpromazine and the untreated chronic schizophrenic: a long-term trial.
    Letemendia FJ; Harris AD
    Br J Psychiatry; 1967 Sep; 113(502):950-8. PubMed ID: 4862704
    [No Abstract]   [Full Text] [Related]  

  • 4. A controlled study of placebo, chlordiazepoxide and chlorpromazine with thirty male schizophrenic patients.
    Hekimian LJ; Friedhoff AJ
    Dis Nerv Syst; 1967 Oct; 28(10):675-8. PubMed ID: 4860896
    [No Abstract]   [Full Text] [Related]  

  • 5. The immediate effects of chlorpromazine in newly admitted schizophrenic patients.
    Hamill WT; Fontana AF
    Am J Psychiatry; 1975 Oct; 132(10):1023-6. PubMed ID: 1101707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-methyldopa-chlorpromazine combination in schizophrenic patients.
    Chouinard G; Annable L
    Neuropsychobiology; 1976; 2(2-3):118-26. PubMed ID: 796755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premorbid asocial adjustment and response to phenothiazine treatment among schizophrenic inpatients.
    Klein DF; Rosen B
    Arch Gen Psychiatry; 1973 Oct; 29(4):480-5. PubMed ID: 4583948
    [No Abstract]   [Full Text] [Related]  

  • 8. Schizophrenic subtypes defined by response to drugs and placebo.
    Goldberg SC; Mattsson NB
    Dis Nerv Syst; 1968 May; 29(5):Suppl:153-8. PubMed ID: 4876985
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative study of butaperazine, chlorpromazine and placebo in chronic schizophrenics.
    Keskiner A; Itil TM; Todt N
    Psychosomatics; 1970; 11(2):120-6. PubMed ID: 4394278
    [No Abstract]   [Full Text] [Related]  

  • 10. Behavior style categories of chronic schizophrenic women.
    Pugh LA; Ray TS
    Arch Gen Psychiatry; 1965 Nov; 13(5):457-63. PubMed ID: 5321272
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative study of 2 drugs and a placebo in chronic schizophrenia].
    Tetreault L
    Actual Pharmacol (Paris); 1969; 22():1-18. PubMed ID: 4927120
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of chronic chlorpromazine administration on systemic arterial pressure in schizophrenic patients: relationship of body position to blood pressure.
    Korol B; Lang WJ; Brown ML; Gershon S
    Clin Pharmacol Ther; 1965; 6(5):587-91. PubMed ID: 5320590
    [No Abstract]   [Full Text] [Related]  

  • 13. Nicotinic acid in the treatment of newly admitted schizophrenic patients: a placebo-controlled study.
    Ananth JV; Vacaflor L; Kekhwa G; Sterlin C; Ban TA
    Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):406-10. PubMed ID: 4261601
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug treatment in newly admitted schizophrenic patients.
    Clark ML; Huber WK; Charalampous KD; Serafetinides EA; Trousdale W; Colmore JP
    Arch Gen Psychiatry; 1971 Nov; 25(5):404-9. PubMed ID: 4943915
    [No Abstract]   [Full Text] [Related]  

  • 15. A controlled double-blind comparison between loxapine succinate and chlorpromazine in acute newly hospitalized schizophrenic patients.
    Shopsin B; Pearson E; Gershon S; Collins P
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):739-48. PubMed ID: 4629112
    [No Abstract]   [Full Text] [Related]  

  • 16. A controlled trial of phenothiazine withdrawal in chronic schizophrenic patients.
    Andrews P; Hall JN; Snaith RP
    Br J Psychiatry; 1976 May; 128():451-5. PubMed ID: 776312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol in schizophrenia. I. Comparison of propranolol, chlorpromazine and placebo.
    Peet M; Bethell MS; Coates A; Khamnee AK; Hall P; Cooper SJ; King DJ; Yates RA
    Br J Psychiatry; 1981 Aug; 139():105-11. PubMed ID: 7030442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of treatment of schizophrenic psychoses with neuroleptics combined with subcomatic insulin].
    Majewski J; Stempurska K
    Psychiatr Pol; 1968; 2(1):37-42. PubMed ID: 4875961
    [No Abstract]   [Full Text] [Related]  

  • 19. Clozapine, chlorpromazine, and placebo in newly hospitalized, acutely schizophrenic patients: a controlled, double-blind comparison.
    Shopsin B; Klein H; Aaronsom M; Collora M
    Arch Gen Psychiatry; 1979 Jun; 36(6):657-64. PubMed ID: 375865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical study of mesoridazine and chlorpromazine in relapsed schizophrenic patients.
    Bankier RG; Mathewson FA
    Dis Nerv Syst; 1972 Aug; 33(8):529-34. PubMed ID: 4567534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.